The global market for Nifedipine Extended Release Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

By inhibiting the calcium channel on the cell membrane, slowing down the inflow of calcium ions, reducing the contractility of the heart and the oxygen consumption of the heart, thereby dilating the coronary arteries, increasing the blood supply to the heart, lowering blood pressure, improving the blood supply to the heart and reducing the burden on the heart. Because it is a sustained-release tablet, the drug is released at a controlled rate, allowing its effects to last for a period of time.

North American market for Nifedipine Extended Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nifedipine Extended Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nifedipine Extended Release Tablets include Valeant Pharmaceuticals, Zydus Pharmaceuticals Inc, Aurobindo Pharma LTD, Pfizer Inc, Sun Pharma Industries LTD, Osmotica Pharmaceuticals, Alkem Laboratories Ltd., Novast Novast Laboratories, LTD, TWi Pharmaceuticals Inc., Shyndec Pharmaceutical Co., Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nifedipine Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Extended Release Tablets.

The Nifedipine Extended Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nifedipine Extended Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nifedipine Extended Release Tablets Market Report

Report Metric	Details
Report Name	Nifedipine Extended Release Tablets Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital Pharmacy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Valeant Pharmaceuticals, Zydus Pharmaceuticals Inc, Aurobindo Pharma LTD, Pfizer Inc, Sun Pharma Industries LTD, Osmotica Pharmaceuticals, Alkem Laboratories Ltd., Novast Novast Laboratories, LTD, TWi Pharmaceuticals Inc., Shyndec Pharmaceutical Co., Ltd, China National Pharmaceutical Industry Co., Ltd, China Resource Pharmaceutical Group Co., Ltd, Anglikang Pharmaceutical Co., Ltd, Warrant Chiral Pharmaceutical Co., Ltd, Tailison Pharmaceutical Co., Ltd, Baheal Medical Inc., Bocheng Pharmaceutical Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Extended Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nifedipine Extended Release Tablets Market report?

Ans: The main players in the Nifedipine Extended Release Tablets Market are Valeant Pharmaceuticals, Zydus Pharmaceuticals Inc, Aurobindo Pharma LTD, Pfizer Inc, Sun Pharma Industries LTD, Osmotica Pharmaceuticals, Alkem Laboratories Ltd., Novast Novast Laboratories, LTD, TWi Pharmaceuticals Inc., Shyndec Pharmaceutical Co., Ltd, China National Pharmaceutical Industry Co., Ltd, China Resource Pharmaceutical Group Co., Ltd, Anglikang Pharmaceutical Co., Ltd, Warrant Chiral Pharmaceutical Co., Ltd, Tailison Pharmaceutical Co., Ltd, Baheal Medical Inc., Bocheng Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Nifedipine Extended Release Tablets Market report?

Ans: The Applications covered in the Nifedipine Extended Release Tablets Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Nifedipine Extended Release Tablets Market report?

Ans: The Types covered in the Nifedipine Extended Release Tablets Market report are Original Drug, Generic Drug

1 Nifedipine Extended Release Tablets Market Overview

1.1 Product Definition

1.2 Nifedipine Extended Release Tablets by Type

1.2.1 Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Nifedipine Extended Release Tablets by Application

1.3.1 Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Global Nifedipine Extended Release Tablets Market Size Estimates and Forecasts

1.4.1 Global Nifedipine Extended Release Tablets Revenue 2020-2031

1.4.2 Global Nifedipine Extended Release Tablets Sales 2020-2031

1.4.3 Global Nifedipine Extended Release Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Nifedipine Extended Release Tablets Market Competition by Manufacturers

2.1 Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nifedipine Extended Release Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application

2.7 Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry

2.8 Global Nifedipine Extended Release Tablets Market Competitive Situation and Trends

2.8.1 Global Nifedipine Extended Release Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nifedipine Extended Release Tablets Players Market Share by Revenue

2.8.3 Global Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nifedipine Extended Release Tablets Market Scenario by Region

3.1 Global Nifedipine Extended Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2031

3.2.1 Global Nifedipine Extended Release Tablets Sales by Region: 2020-2025

3.2.2 Global Nifedipine Extended Release Tablets Sales by Region: 2026-2031

3.3 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2031

3.3.1 Global Nifedipine Extended Release Tablets Revenue by Region: 2020-2025

3.3.2 Global Nifedipine Extended Release Tablets Revenue by Region: 2026-2031

3.4 North America Nifedipine Extended Release Tablets Market Facts & Figures by Country

3.4.1 North America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nifedipine Extended Release Tablets Sales by Country (2020-2031)

3.4.3 North America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nifedipine Extended Release Tablets Market Facts & Figures by Country

3.5.1 Europe Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nifedipine Extended Release Tablets Sales by Country (2020-2031)

3.5.3 Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nifedipine Extended Release Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Nifedipine Extended Release Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Nifedipine Extended Release Tablets Market Facts & Figures by Country

3.7.1 Latin America Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2031)

3.7.3 Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nifedipine Extended Release Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Nifedipine Extended Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2031)

4.1.1 Global Nifedipine Extended Release Tablets Sales by Type (2020-2025)

4.1.2 Global Nifedipine Extended Release Tablets Sales by Type (2026-2031)

4.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2031)

4.2 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2031)

4.2.1 Global Nifedipine Extended Release Tablets Revenue by Type (2020-2025)

4.2.2 Global Nifedipine Extended Release Tablets Revenue by Type (2026-2031)

4.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Nifedipine Extended Release Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2031)

5.1.1 Global Nifedipine Extended Release Tablets Sales by Application (2020-2025)

5.1.2 Global Nifedipine Extended Release Tablets Sales by Application (2026-2031)

5.1.3 Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2031)

5.2 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2031)

5.2.1 Global Nifedipine Extended Release Tablets Revenue by Application (2020-2025)

5.2.2 Global Nifedipine Extended Release Tablets Revenue by Application (2026-2031)

5.2.3 Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Nifedipine Extended Release Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Valeant Pharmaceuticals

6.1.1 Valeant Pharmaceuticals Company Information

6.1.2 Valeant Pharmaceuticals Description and Business Overview

6.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio

6.1.5 Valeant Pharmaceuticals Recent Developments/Updates

6.2 Zydus Pharmaceuticals Inc

6.2.1 Zydus Pharmaceuticals Inc Company Information

6.2.2 Zydus Pharmaceuticals Inc Description and Business Overview

6.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolio

6.2.5 Zydus Pharmaceuticals Inc Recent Developments/Updates

6.3 Aurobindo Pharma LTD

6.3.1 Aurobindo Pharma LTD Company Information

6.3.2 Aurobindo Pharma LTD Description and Business Overview

6.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolio

6.3.5 Aurobindo Pharma LTD Recent Developments/Updates

6.4 Pfizer Inc

6.4.1 Pfizer Inc Company Information

6.4.2 Pfizer Inc Description and Business Overview

6.4.3 Pfizer Inc Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Inc Nifedipine Extended Release Tablets Product Portfolio

6.4.5 Pfizer Inc Recent Developments/Updates

6.5 Sun Pharma Industries LTD

6.5.1 Sun Pharma Industries LTD Company Information

6.5.2 Sun Pharma Industries LTD Description and Business Overview

6.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolio

6.5.5 Sun Pharma Industries LTD Recent Developments/Updates

6.6 Osmotica Pharmaceuticals

6.6.1 Osmotica Pharmaceuticals Company Information

6.6.2 Osmotica Pharmaceuticals Description and Business Overview

6.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolio

6.6.5 Osmotica Pharmaceuticals Recent Developments/Updates

6.7 Alkem Laboratories Ltd.

6.7.1 Alkem Laboratories Ltd. Company Information

6.7.2 Alkem Laboratories Ltd. Description and Business Overview

6.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolio

6.7.5 Alkem Laboratories Ltd. Recent Developments/Updates

6.8 Novast Novast Laboratories, LTD

6.8.1 Novast Novast Laboratories, LTD Company Information

6.8.2 Novast Novast Laboratories, LTD Description and Business Overview

6.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolio

6.8.5 Novast Novast Laboratories, LTD Recent Developments/Updates

6.9 TWi Pharmaceuticals Inc.

6.9.1 TWi Pharmaceuticals Inc. Company Information

6.9.2 TWi Pharmaceuticals Inc. Description and Business Overview

6.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolio

6.9.5 TWi Pharmaceuticals Inc. Recent Developments/Updates

6.10 Shyndec Pharmaceutical Co., Ltd

6.10.1 Shyndec Pharmaceutical Co., Ltd Company Information

6.10.2 Shyndec Pharmaceutical Co., Ltd Description and Business Overview

6.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.10.5 Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates

6.11 China National Pharmaceutical Industry Co., Ltd

6.11.1 China National Pharmaceutical Industry Co., Ltd Company Information

6.11.2 China National Pharmaceutical Industry Co., Ltd Description and Business Overview

6.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.11.5 China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates

6.12 China Resource Pharmaceutical Group Co., Ltd

6.12.1 China Resource Pharmaceutical Group Co., Ltd Company Information

6.12.2 China Resource Pharmaceutical Group Co., Ltd Description and Business Overview

6.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.12.4 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.12.5 China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates

6.13 Anglikang Pharmaceutical Co., Ltd

6.13.1 Anglikang Pharmaceutical Co., Ltd Company Information

6.13.2 Anglikang Pharmaceutical Co., Ltd Description and Business Overview

6.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.13.5 Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates

6.14 Warrant Chiral Pharmaceutical Co., Ltd

6.14.1 Warrant Chiral Pharmaceutical Co., Ltd Company Information

6.14.2 Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview

6.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.14.5 Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates

6.15 Tailison Pharmaceutical Co., Ltd

6.15.1 Tailison Pharmaceutical Co., Ltd Company Information

6.15.2 Tailison Pharmaceutical Co., Ltd Description and Business Overview

6.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.15.5 Tailison Pharmaceutical Co., Ltd Recent Developments/Updates

6.16 Baheal Medical Inc.

6.16.1 Baheal Medical Inc. Company Information

6.16.2 Baheal Medical Inc. Description and Business Overview

6.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolio

6.16.5 Baheal Medical Inc. Recent Developments/Updates

6.17 Bocheng Pharmaceutical Co., Ltd

6.17.1 Bocheng Pharmaceutical Co., Ltd Company Information

6.17.2 Bocheng Pharmaceutical Co., Ltd Description and Business Overview

6.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolio

6.17.5 Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nifedipine Extended Release Tablets Industry Chain Analysis

7.2 Nifedipine Extended Release Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nifedipine Extended Release Tablets Production Mode & Process Analysis

7.4 Nifedipine Extended Release Tablets Sales and Marketing

7.4.1 Nifedipine Extended Release Tablets Sales Channels

7.4.2 Nifedipine Extended Release Tablets Distributors

7.5 Nifedipine Extended Release Tablets Customer Analysis

8 Nifedipine Extended Release Tablets Market Dynamics

8.1 Nifedipine Extended Release Tablets Industry Trends

8.2 Nifedipine Extended Release Tablets Market Drivers

8.3 Nifedipine Extended Release Tablets Market Challenges

8.4 Nifedipine Extended Release Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Valeant Pharmaceuticals

Zydus Pharmaceuticals, Inc.

Aurobindo Pharma Ltd.

Pfizer Inc

Osmotica Pharmaceuticals

Alkem Laboratories Ltd.

TWi Pharmaceuticals, Inc.

Sun Pharma Industries LTD

Novast Novast Laboratories, LTD

Shyndec Pharmaceutical Co., Ltd

China National Pharmaceutical Industry Co., Ltd

China Resource Pharmaceutical Group Co., Ltd

Anglikang Pharmaceutical Co., Ltd

Warrant Chiral Pharmaceutical Co., Ltd

Tailison Pharmaceutical Co., Ltd

Baheal Medical Inc.

Bocheng Pharmaceutical Co., Ltd

List of Tables

Table 1. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nifedipine Extended Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Nifedipine Extended Release Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Nifedipine Extended Release Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Nifedipine Extended Release Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Nifedipine Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Nifedipine Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nifedipine Extended Release Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nifedipine Extended Release Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Nifedipine Extended Release Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nifedipine Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Extended Release Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Nifedipine Extended Release Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Nifedipine Extended Release Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Nifedipine Extended Release Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Nifedipine Extended Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Nifedipine Extended Release Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Nifedipine Extended Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Nifedipine Extended Release Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Nifedipine Extended Release Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Nifedipine Extended Release Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Nifedipine Extended Release Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. Valeant Pharmaceuticals Company Information

Table 71. Valeant Pharmaceuticals Description and Business Overview

Table 72. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product

Table 74. Valeant Pharmaceuticals Recent Developments/Updates

Table 75. Zydus Pharmaceuticals Inc Company Information

Table 76. Zydus Pharmaceuticals Inc Description and Business Overview

Table 77. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product

Table 79. Zydus Pharmaceuticals Inc Recent Developments/Updates

Table 80. Aurobindo Pharma LTD Company Information

Table 81. Aurobindo Pharma LTD Description and Business Overview

Table 82. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product

Table 84. Aurobindo Pharma LTD Recent Developments/Updates

Table 85. Pfizer Inc Company Information

Table 86. Pfizer Inc Description and Business Overview

Table 87. Pfizer Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Inc Nifedipine Extended Release Tablets Product

Table 89. Pfizer Inc Recent Developments/Updates

Table 90. Sun Pharma Industries LTD Company Information

Table 91. Sun Pharma Industries LTD Description and Business Overview

Table 92. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product

Table 94. Sun Pharma Industries LTD Recent Developments/Updates

Table 95. Osmotica Pharmaceuticals Company Information

Table 96. Osmotica Pharmaceuticals Description and Business Overview

Table 97. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product

Table 99. Osmotica Pharmaceuticals Recent Developments/Updates

Table 100. Alkem Laboratories Ltd. Company Information

Table 101. Alkem Laboratories Ltd. Description and Business Overview

Table 102. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product

Table 104. Alkem Laboratories Ltd. Recent Developments/Updates

Table 105. Novast Novast Laboratories, LTD Company Information

Table 106. Novast Novast Laboratories, LTD Description and Business Overview

Table 107. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product

Table 109. Novast Novast Laboratories, LTD Recent Developments/Updates

Table 110. TWi Pharmaceuticals Inc. Company Information

Table 111. TWi Pharmaceuticals Inc. Description and Business Overview

Table 112. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product

Table 114. TWi Pharmaceuticals Inc. Recent Developments/Updates

Table 115. Shyndec Pharmaceutical Co., Ltd Company Information

Table 116. Shyndec Pharmaceutical Co., Ltd Description and Business Overview

Table 117. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product

Table 119. Shyndec Pharmaceutical Co., Ltd Recent Developments/Updates

Table 120. China National Pharmaceutical Industry Co., Ltd Company Information

Table 121. China National Pharmaceutical Industry Co., Ltd Description and Business Overview

Table 122. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product

Table 124. China National Pharmaceutical Industry Co., Ltd Recent Developments/Updates

Table 125. China Resource Pharmaceutical Group Co., Ltd Company Information

Table 126. China Resource Pharmaceutical Group Co., Ltd Description and Business Overview

Table 127. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product

Table 129. China Resource Pharmaceutical Group Co., Ltd Recent Developments/Updates

Table 130. Anglikang Pharmaceutical Co., Ltd Company Information

Table 131. Anglikang Pharmaceutical Co., Ltd Description and Business Overview

Table 132. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product

Table 134. Anglikang Pharmaceutical Co., Ltd Recent Developments/Updates

Table 135. Warrant Chiral Pharmaceutical Co., Ltd Company Information

Table 136. Warrant Chiral Pharmaceutical Co., Ltd Description and Business Overview

Table 137. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product

Table 139. Warrant Chiral Pharmaceutical Co., Ltd Recent Developments/Updates

Table 140. Tailison Pharmaceutical Co., Ltd Company Information

Table 141. Tailison Pharmaceutical Co., Ltd Description and Business Overview

Table 142. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product

Table 144. Tailison Pharmaceutical Co., Ltd Recent Developments/Updates

Table 145. Baheal Medical Inc. Company Information

Table 146. Baheal Medical Inc. Description and Business Overview

Table 147. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Baheal Medical Inc. Nifedipine Extended Release Tablets Product

Table 149. Baheal Medical Inc. Recent Developments/Updates

Table 150. Bocheng Pharmaceutical Co., Ltd Company Information

Table 151. Bocheng Pharmaceutical Co., Ltd Description and Business Overview

Table 152. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product

Table 154. Bocheng Pharmaceutical Co., Ltd Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Nifedipine Extended Release Tablets Distributors List

Table 158. Nifedipine Extended Release Tablets Customers List

Table 159. Nifedipine Extended Release Tablets Market Trends

Table 160. Nifedipine Extended Release Tablets Market Drivers

Table 161. Nifedipine Extended Release Tablets Market Challenges

Table 162. Nifedipine Extended Release Tablets Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nifedipine Extended Release Tablets

Figure 2. Global Nifedipine Extended Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nifedipine Extended Release Tablets Market Share by Type: 2024 & 2031

Figure 4. Original Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Nifedipine Extended Release Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Nifedipine Extended Release Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Pharmacy

Figure 10. Others

Figure 11. Global Nifedipine Extended Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Nifedipine Extended Release Tablets Market Size (2020-2031) & (US$ Million)

Figure 13. Global Nifedipine Extended Release Tablets Sales (2020-2031) & (K Units)

Figure 14. Global Nifedipine Extended Release Tablets Average Price (US$/Unit) & (2020-2031)

Figure 15. Nifedipine Extended Release Tablets Report Years Considered

Figure 16. Nifedipine Extended Release Tablets Sales Share by Manufacturers in 2024

Figure 17. Global Nifedipine Extended Release Tablets Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Nifedipine Extended Release Tablets Players: Market Share by Revenue in Nifedipine Extended Release Tablets in 2024

Figure 19. Nifedipine Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Nifedipine Extended Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)

Figure 22. North America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)

Figure 23. United States Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)

Figure 26. Europe Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)

Figure 27. Germany Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Nifedipine Extended Release Tablets Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Nifedipine Extended Release Tablets Revenue Market Share by Region (2020-2031)

Figure 34. China Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)

Figure 42. Latin America Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Nifedipine Extended Release Tablets Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Nifedipine Extended Release Tablets Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Nifedipine Extended Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)

Figure 52. Global Revenue Market Share of Nifedipine Extended Release Tablets by Type (2020-2031)

Figure 53. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)

Figure 55. Global Revenue Market Share of Nifedipine Extended Release Tablets by Application (2020-2031)

Figure 56. Global Nifedipine Extended Release Tablets Price (US$/Unit) by Application (2020-2031)

Figure 57. Nifedipine Extended Release Tablets Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions